| 1 | 1 | | I |
|---|
| 2 | 2 | | 119THCONGRESS |
|---|
| 3 | 3 | | 1 |
|---|
| 4 | 4 | | STSESSION H. R. 2404 |
|---|
| 5 | 5 | | To provide for a study on the effects of remote monitoring on individuals |
|---|
| 6 | 6 | | who are prescribed opioids. |
|---|
| 7 | 7 | | IN THE HOUSE OF REPRESENTATIVES |
|---|
| 8 | 8 | | MARCH27, 2025 |
|---|
| 9 | 9 | | Mr. B |
|---|
| 10 | 10 | | ALDERSON(for himself and Ms. KELLYof Illinois) introduced the |
|---|
| 11 | 11 | | following bill; which was referred to the Committee on Energy and Commerce |
|---|
| 12 | 12 | | A BILL |
|---|
| 13 | 13 | | To provide for a study on the effects of remote monitoring |
|---|
| 14 | 14 | | on individuals who are prescribed opioids. |
|---|
| 15 | 15 | | Be it enacted by the Senate and House of Representa-1 |
|---|
| 16 | 16 | | tives of the United States of America in Congress assembled, 2 |
|---|
| 17 | 17 | | SECTION 1. SHORT TITLE. 3 |
|---|
| 18 | 18 | | This Act may be cited as the ‘‘Remote Opioid Moni-4 |
|---|
| 19 | 19 | | toring Act of 2025’’. 5 |
|---|
| 20 | 20 | | SEC. 2. PROVIDING FOR A STUDY ON THE EFFECTS OF RE-6 |
|---|
| 21 | 21 | | MOTE MONITORING ON INDIVIDUALS WHO 7 |
|---|
| 22 | 22 | | ARE PRESCRIBED OPIOIDS. 8 |
|---|
| 23 | 23 | | (a) I |
|---|
| 24 | 24 | | NGENERAL.—Not later than 18 months after 9 |
|---|
| 25 | 25 | | the date of enactment of this Act, the Comptroller General 10 |
|---|
| 26 | 26 | | VerDate Sep 11 2014 21:28 Apr 02, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H2404.IH H2404 |
|---|
| 27 | 27 | | ssavage on LAPJG3WLY3PROD with BILLS 2 |
|---|
| 28 | 28 | | •HR 2404 IH |
|---|
| 29 | 29 | | of the United States shall conduct a study and submit to 1 |
|---|
| 30 | 30 | | the Committee on Energy and Commerce of the House 2 |
|---|
| 31 | 31 | | of Representatives and the Committee on Health, Edu-3 |
|---|
| 32 | 32 | | cation, Labor, and Pensions and the Committee on Fi-4 |
|---|
| 33 | 33 | | nance of the Senate a report on the use of remote moni-5 |
|---|
| 34 | 34 | | toring with respect to individuals who are prescribed 6 |
|---|
| 35 | 35 | | opioids. 7 |
|---|
| 36 | 36 | | (b) R |
|---|
| 37 | 37 | | EPORT.—The report described in subsection (a) 8 |
|---|
| 38 | 38 | | shall include— 9 |
|---|
| 39 | 39 | | (1) an assessment of scientific evidence related 10 |
|---|
| 40 | 40 | | to the efficacy, individual outcomes, and potential 11 |
|---|
| 41 | 41 | | cost savings associated with remote monitoring for 12 |
|---|
| 42 | 42 | | individuals who are prescribed opioids compared to 13 |
|---|
| 43 | 43 | | such individuals who are not so monitored; 14 |
|---|
| 44 | 44 | | (2) an assessment of the current prevalence of 15 |
|---|
| 45 | 45 | | remote monitoring for individuals who are prescribed 16 |
|---|
| 46 | 46 | | opioids, including the use of such monitoring for 17 |
|---|
| 47 | 47 | | such individuals in other countries; and 18 |
|---|
| 48 | 48 | | (3) recommendations to improve availability, ac-19 |
|---|
| 49 | 49 | | cess, and coverage for remote monitoring for individ-20 |
|---|
| 50 | 50 | | uals who are prescribed opioids, including through 21 |
|---|
| 51 | 51 | | changes to Federal health care programs (as defined 22 |
|---|
| 52 | 52 | | in section 1128B of the Social Security Act (42 23 |
|---|
| 53 | 53 | | U.S.C. 1320a–7b)) and, if determined appropriate 24 |
|---|
| 54 | 54 | | by the Comptroller General, an identification of co-25 |
|---|
| 55 | 55 | | VerDate Sep 11 2014 21:28 Apr 02, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H2404.IH H2404 |
|---|
| 56 | 56 | | ssavage on LAPJG3WLY3PROD with BILLS 3 |
|---|
| 57 | 57 | | •HR 2404 IH |
|---|
| 58 | 58 | | horts of individuals who stand to benefit the most 1 |
|---|
| 59 | 59 | | from remote monitoring when prescribed opioids. 2 |
|---|
| 60 | 60 | | Æ |
|---|
| 61 | 61 | | VerDate Sep 11 2014 21:28 Apr 02, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6301 E:\BILLS\H2404.IH H2404 |
|---|
| 62 | 62 | | ssavage on LAPJG3WLY3PROD with BILLS |
|---|